Two Sigma Investments, LP Fulgent Genetics, Inc. Call Options Transaction History

Two Sigma Investments, LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$49.85 - $96.11 $1.07 Million - $2.07 Million	-21,500 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$77.3 - $105.0 $881,220 - $1.2 Million	-11,400 Reduced 34.65%	21,500 $2.16 Million
Q3 2021 Nov 15, 2021	SELL	$74.87 - $110.87 $142,253 - $210,653	-1,900 Reduced 5.46%	32,900 $2.96 Million
Q2 2021 Aug 16, 2021	BUY	$66.8 - $100.45 $1.74 Million - $2.61 Million	26,000 Added 295.45%	34,800 $3.21 Million
Q1 2021 May 17, 2021	BUY	$59.3 - $183.85 $521,840 - $1.62 Million	8,800 New	8,800 $850,000

200

16M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $555M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.